← Leaderboards
Tao Dao
Sloan-Kettering Inst Can Research
$540,804
Attributed
$540,804
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $135.2K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$540,804 · 1
By mechanism
R50$540,804 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- James A Fagin$27,970,638
- Hsuan-An Chen$533,167
- Alan L. Ho$4,883,159
- Polly D. Gregor$1,219,191
- Katharine C Hsu$29,362,365
Others in their field
Other Rising Stars on “Amino Acids”
- Rino Rappuoli · Washington University$14,702,884
- Steven Bradfute · Albert Einstein College Of Medicine$3,407,726
- Daniel Paech · Brigham And Women'S Hospital$3,155,815
- Yun Chen · Johns Hopkins University$3,000,000
- Nam-Joon Cho · Stanford University$2,909,919
- Vadim Gurvich · University Of Minnesota$2,852,434
Research focus
Amino Acids3-DimensionalAntigen Presentation PathwayAntigensAntibodiesBispecific AntibodiesCancer CellCell LineCell SurfaceCervix CarcinomaBiopsyComplexCostCytotoxic AgentDoseEngineeringEpitopesFlexibilityHalf-LifeHistocompatibility Antigens Class IHistocompatibility Antigens Class IiHla-A GeneChimeric Antigen ReceptorHuman Papillomavirus
Grant awards (4)
Developing therapeutic TCR mimic monoclonal antibodies for cancer$135,201
R50 · FY2025 · CA · contact PI
Developing therapeutic TCR mimic monoclonal antibodies for cancer$135,201
R50 · FY2024 · CA · contact PI
Developing therapeutic TCR mimic monoclonal antibodies for cancer$135,201
R50 · FY2023 · CA · contact PI
Developing therapeutic TCR mimic monoclonal antibodies for cancer$135,201
R50 · FY2022 · CA · contact PI